达巴万星前体A40926 B生产菌种的基因工程改造
[Abstract]:Nonomuraea sp.ATCC 39727 can produce component A40926B by secondary metabolism, which can be used as precursor of dabavanxin, a new glycopeptide antibiotic, which is similar to teicoplanin in structure and has stronger activity and longer half-life in clinical trials. On the basis of mutagenesis and protoplast mutagenesis of mutant strain A416-B4 in the early stage of laboratory, genetic engineering was carried out to simplify the production process and increase the yield of A40926B, thus laying a foundation for industrial production. First of all, the genetic operating system of A416-B4 was optimized for conjugation transfer (knockout). On the basis of the optimized genetic operating system, the dbv23 knockout plasmid pKdbv23, of knockout acetyltransferase gene was constructed, and the engineering strain A416- dbv23. was obtained by using homologous recombination double exchange knockout dbv23 gene. The main product of the fermentation was A40926B, but no A40926 PB was produced, and the fermentation unit of A40926B in shaking flask reached 1577 mg/L, which was 94 494% higher than that of the original strain A416-B4. An integrated expression plasmid containing two regulatory genes, dbv3,dbv4, was constructed, two plasmids were integrated into A416- dbv23, and two engineering strains, A416- dbv23-dbv3,A416- dbv23-dbv4., were obtained. The fermentation of engineering bacteria was investigated. The results showed that the effect of introducing dbv4 gene was slightly better than that of dbv3,A416- dbv23-dbv4. The shaking flask unit reached 1707 mg/L, and increased 8.2% compared with A416- dbv23, and 110% higher than the original strain A416-B4.
【学位授予单位】:上海医药工业研究院
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:Q78;TQ927
【参考文献】
相关期刊论文 前8条
1 李煜;张菁;;FDA批准Dalvance(达巴万星)用于治疗皮肤感染[J];中国感染与化疗杂志;2015年04期
2 PAN WenQin;KANG QianJin;WANG Lei;BAI LinQuan;DENG ZiXin;;Asm8, a specific LAL-type activator of 3-amino-5-hydroxy-benzoate biosynthesis in ansamitocin production[J];Science China(Life Sciences);2013年07期
3 龙燕;黄运昌;朱春燕;莫洪;朱辉;;糖肽类抗生素A40926高产菌株的选育[J];中国医药工业杂志;2013年02期
4 黄灵丽;沈晓放;陈少欣;;糖肽类抗生素A40926B产生菌的培养基优化及菌种选育[J];中国医药工业杂志;2012年04期
5 沈晓放;陈少欣;;半合成糖肽类抗生素达巴万星前体A40926的生物合成[J];中国医药工业杂志;2010年02期
6 李航;阮林高;魏维;朱丽;陈代杰;戈梅;;东方拟无枝酸菌HCCB10007中vcm8基因的敲除及无氯万古霉素产生菌的构建[J];中国新药杂志;2010年01期
7 周雨朦;洪文荣;阮林高;陈代杰;戈梅;;氯离子对东方拟无枝酸菌发酵产物的影响[J];中国抗生素杂志;2008年05期
8 尚新艳;阮丽军;许激扬;陈代杰;;第二代糖肽类抗生素的研究进展[J];中国抗生素杂志;2007年05期
,本文编号:2263964
本文链接:https://www.wllwen.com/kejilunwen/jiyingongcheng/2263964.html